Abbott Labs Stock Offers Favorable Entry Point Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.9015 of 5 stars$133.920.0%1.76%17.51 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored7 High-Growth Stocks Under $10 Many risk-tolerant investors love to find high-growth stocks trading under $10. They understand that this is...MarketBeatMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored7 Best Stocks to Own Right NowToday, we invite you to view our list of the seven best stocks to own for the next thirty days. Why is it w...MarketBeatURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored7 Stocks Changing the World—and Making Investors Wealthy Technology is evolving faster than ever. Disruptive technology that was seen as groundbreaking just a decade...MarketBeat Listen to MarketBeat Other Platforms Recent Videos Featured Articles and OffersRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMay 5, 2025View Rocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsThe Trump Dump is starting; Get out of stocks now?From Paradigm Press(Ad)View The Trump Dump is starting; Get out of stocks now?Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernMay 2, 2025View Palantir Earnings: 1 Bullish Signal and 1 Area of Concern3 Mid-Cap Medical Stocks Outperforming the MarketMay 6, 2025View 3 Mid-Cap Medical Stocks Outperforming the MarketUPS Stock Forecast: Rebound Underway for United Parcel Service?May 4, 2025View UPS Stock Forecast: Rebound Underway for United Parcel Service?URGENT: This Altcoin Opportunity Won’t Wait – Act NowFrom Crypto Swap Profits(Ad)View URGENT: This Altcoin Opportunity Won’t Wait – Act Now Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.9015 of 5 stars$133.920.0%1.76%17.51 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored7 High-Growth Stocks Under $10 Many risk-tolerant investors love to find high-growth stocks trading under $10. They understand that this is...MarketBeatMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored7 Best Stocks to Own Right NowToday, we invite you to view our list of the seven best stocks to own for the next thirty days. Why is it w...MarketBeatURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored7 Stocks Changing the World—and Making Investors Wealthy Technology is evolving faster than ever. Disruptive technology that was seen as groundbreaking just a decade...MarketBeat
